Development and Validation of a Prognostic Nomogram for Predicting Hypostatic Pneumonia Risk in Large Vessel Occlusion Stroke after Endovascular Therapy Patients

Jingling Zhu¹Wenfei Liang¹Yu Ding¹Xiaohua He¹Jiasheng Zhao¹Guoshun Li¹Zhaobang Chen¹Kangqiang Yang¹Xiaoling Wu¹Bin Liao¹Huiquan Deng¹Zichong Liang¹Zhan Zhao¹Jingyi Chen¹Qiuxing He^1,2,3Weimin Ning^1,2,3*

• ¹Dongguan Hospital of Traditional Chinese Medicine, Dongguan, China
• ²Dongguan Key Laboratory of Intractable Brain Diseases in Dongguan, Dongguan, China
• ³State Key Laboratory of Dampness Syndrome of Chinese Medicine, Guangzhou, China

Background: Post-stroke hypostatic pneumonia(HP) significantly impairs neurological recovery and worsens prognosis in patients with acute ischemic stroke with large vessel occlusion (AIS-LVO). This study aimed to develop and validate a prognostic nomogram for predicting hypostatic pneumonia risk following endovascular therapy (EVT) in AIS-LVO patients . Methods: We retrospectively analyzed 650 consecutive AIS-LVO patients who underwent endovascular therapy with mechanical ventilation at Dongguan Hospital of Guangzhou University of Chinese Medicine from September 2018 to March 2025. After applying inclusion/exclusion criteria, 412 patients were randomly split into two groups: training (n=288) and validation (n=124), maintaining a 7:3 ratio. Using least absolute shrinkage and selection operator (LASSO) regression for feature selection followed by multivariable logistic regression, we identified independent predictors for nomogram construction. Model performance was assessed through the receiver operating characteristic curve (ROC), calibration curve,decision curve analysis (DCA), and clinical impact curve (CIC). Results: Four independent predictors were identified: admission Glasgow Coma Scale (GCS) score (OR 0.77, 95% CI 0.68–0.86), postoperative 48 h fever (OR 2.77, 95% CI 1.52–5.02), postoperative 48 h neutrophil-to-lymphocyte ratio (NLR) (OR 1.15, 95% CI 1.08–1.22), and ASPECTS ( OR 0.74, 95% CI 0.63–0.87). The model had an area under the curve (AUC) of 0.829 (95% CI: 0.781–0.877) in the training cohort and 0.817 (95% CI 0.732–0.903) in the validation cohort, which means it was good at making predictions.Calibration curves revealed good alignment between predicted and observed probabilities in the training cohort. The validation cohort retained satisfactory calibration, with only modest overestimation of risk. DCA and CIC consistently indicated the nomogram ' s applicability in diverse clinical settings. Conclusion: We developed and validated an effective nomogram incorporating four clinically accessible parameters to predict the risk of hypostatic pneumonia after EVT. This tool may facilitate early high-risk patient identification and guide preventive therapy to improve clinical outcomes.